Bumetanide (nasal)

  • Part D specialty tier in 57% of formularies (2026Q3)
  • Enbumyst

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Bumetanide (nasal): storage and handling

Freezing
Do not freeze
Label statement
Do not freeze.
Room temperature
at or below 25°C (77°F)
Label statement
Store at room temperature 59°F to 77°F (15°C to 25°C).
Room temperature
at or below 25°C (77°F)
Label statement
Storing ENBUMYST Store in carton at room temperature of 59°F to 77°F (15°C to 25°C).
Room temperature
at or below 25°C (77°F)
Label statement
Store ENBUMYST at room temperature between 59°F to 77°F (15°C to 25°C).
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 25°C (77°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Store at room temperature 59°F to 77°F (15°C to 25°C).

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1 877 300 5339 (the number printed on the label) about this product.

Where the label prints this number
For more information visit ENBUMYST.com or call 1 877 300 5339 This Instructions for Use has been approved by the U.S.
All storage statements on the label (6)
  • Store at room temperature 59°F to 77°F (15°C to 25°C).
  • Short-term excursions permitted between 39°F to 104°F (4°C to 40°C).
  • Do not freeze.
  • Storing ENBUMYST Store in carton at room temperature of 59°F to 77°F (15°C to 25°C).
  • Store ENBUMYST at room temperature between 59°F to 77°F (15°C to 25°C).
  • Do not freeze .

FDA label version 4, effective August 27, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

2%of plans list it
0%of those: prior authorization
0%step therapy
100%quantity limit
52%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.